Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172)
Paul Nathan, Paolo A. Ascierto, John B.A.G. Haanen, Enrique Espinosa, Лев Вадимович Демидов, Claus Garbe and 22 more
- Rank
- 47 of 538
- Percentile
- top 8.8%
- Where
- European Journal of Cancer, 2019
- Citations
- 97
From the 2019 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.